Quoted from http://www.reuters.com/article/2014/08/29/takeda-pharma-actos-idUSL1N0QZ07I20140829
Takeda, Lilly lose bid to overturn $9 bln award for hiding cancer risk
Fri Aug 29, 2014 1:10am EDT
Aug 28 (Reuters) - Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a bid to overturn a combined $9 billion punitive damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.
"Plaintiffs have pointed to sufficient evidence from which the jury could have concluded that the 'information' about bladder cancer contained in Actos labels did not adequately warn of the increased risk of cancer," U.S. District Judge Rebecca Doherty of the Western District of Louisiana said on Wednesday.
The development is a setback for Takeda but leaves open the possibility of a retrial or reduced verdict, for which Japan's top drugmaker made a separate appeal in April.
[Article continues at original source]